Online Event: Promoting and Protecting Innovation in the Bioeconomy
The event will be webcast live from this page.
The Center for Strategic and International Studies (CSIS) invites you to attend the third event in our Synthetic Biology: The Ongoing Technology Revolution Series. This event will discuss synthetic biology’s potential to drive both economic growth and positive social change. It will also consider the risks associated with synthetic biology and opportunities to manage those risks while simultaneously accelerating innovation throughout the bioeconomy. This event will feature Mr. Ian Watson (Deputy Assistant Secretary, Acting Director, Office of Strategy, Policy, Planning, and Requirements of the Department of Health and Human Services), Ms. Katie Rae (CEO and Managing Partner of The Engine), and Mr. Edward You (Supervisory Special Agent at the Federal Bureau of Investigation). More speakers to be announced.
Emerging technologies—such as artificial intelligence, quantum computing, 5G, and synthetic biology—drive security and economic competition and are increasingly shaping national strategies. To develop an effective strategy for synthetic biology, policy makers and the general public need a better understanding of synthetic biology’s underlying capabilities, state of development, and diverse applications. Through a series of four symposia, CSIS will explore synthetic biology’s wide-ranging applications—from advanced microelectronics and materials to nutrition and cosmetics —and opportunities to shape its future development in support of U.S. security and economic interests. This series will include targeted discussions on synthetic biology’s:
- Present and future potential as a critical emerging technology;
- Economic and societal implications;
- National security opportunities and risks; and
- Implications for emerging technology policy.
CSIS hopes you will join us for our third event on June 17th and will also tune in to watch past events, which are available online.
This series of events is sponsored by Ginkgo Bioworks, Inc.
